Challenges in metabolomics-based disease molecular classification: an analytical perspective

Bioanalysis. 2017 May;9(10):771-773. doi: 10.4155/bio-2017-4998. Epub 2017 May 18.

Authors

Yiqiao Gao^{1

2}, Quan Liu³, Fengguo Xu^{1

2}

Affiliations

¹ Key Laboratory of Drug Quality Control & Pharmacovigilance, China Pharmaceutical University, Nanjing 210009, PR China.
² State Key Laboratory of Natural Medicine, China Pharmaceutical University, Nanjing 210009, PR China.
³ The Department of Medical Oncology, Affiliated Hospital of Jiangnan University & Fourth People's Hospital of Wuxi, Wuxi 214062, PR China.

PMID: 28520467
DOI: 10.4155/bio-2017-4998

No abstract available

Keywords: analytical technology; metabolomics; molecular classification; precision medicine.

Publication types

Editorial

MeSH terms

Biomarkers / analysis
Biomarkers / metabolism
Diabetes Mellitus, Type 2 / classification
Diabetes Mellitus, Type 2 / metabolism
Humans
Metabolome
Metabolomics / methods*
Neoplasms / classification
Neoplasms / metabolism
Precision Medicine / methods*

Substances

Biomarkers